Bayer Study Shows Potential Of Saliva-Based Biomarker For Healthy Aging

Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”

Epigenetic patterns from saliva can be used to capture information about inflammation, a key risk factor for multiple diseases (Shutterstock)

More from Innovation & IP

More from Digital Technologies